Effect of Irbesartan on Chemerin in the Renal Tissues of Diabetic Rats
Background/Aims: Chemerin was introduced as a novel adipokine that plays a crucial role in insulin signaling and diabetic nephropathy. Serum chemerin levels are significantly elevated in type 2 diabetes patients with macroalbuminuria. However, the underlying mechanisms remain unclear. We conducted a...
Main Authors: | Qiu-Xia Yu, Hong Zhang, Wen-Hui Xu, Fei Hao, Su-Lai Liu, Meng-Meng Bai, Jia-Wei Mu, Hui-Juan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2015-09-01
|
Series: | Kidney & Blood Pressure Research |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/368523 |
Similar Items
-
IRBESARTAN IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2015-09-01) -
Observational study on patients’ compliance with Irbesartan in essential hypertension “I Comply”
by: K. Leon, et al.
Published: (2014-03-01) -
Effect of Danhong injection combined with irbesartan on oxidative stress and renal function damage in patients with diabetic nephropathy
by: Zhen Dong, et al.
Published: (2017-08-01) -
Effect of calcium dobesilate combined with irbesartan therapy on proteinuria and serum inflammatory mediator levels in early diabetic nephropathy
by: Jing Hou
Published: (2016-09-01) -
Irbesartan Ameliorates Lipid Deposition by Enhancing Autophagy via PKC/AMPK/ULK1 Axis in Free Fatty Acid Induced Hepatocytes
by: Juan He, et al.
Published: (2019-05-01)